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Abstract
Background:  Osteoporosis and osteoporotic fracture in men are significant public health
problems in an aging society. However, information on male osteoporosis remains impressively
lacking, especially for Asians. We designed the Fujiwara-kyo Osteoporosis Risk in Men (FORMEN)
study as an ancillary study of a cohort study, the Fujiwara-kyo study, to determine risk factors for
osteoporotic fractures in Japanese men.
Methods/Design: Design: A community-based single-centre prospective cohort study with at
least a 5-year follow-up
Subjects: All the male participants of the Fujiwara-kyo study who were living in the four cities
studied, aged 65 years and older, and able to walk without aid from others.
Primary outcome: Incidence of osteoporotic fractures including vertebral and clinical non-
vertebral fractures.
Additional outcomes: Change in bone mineral density (BMD), change in hip geometry, onset of
receiving benefits from Long-term Care Insurance (LCI), health-related quality of life, and mortality.
Baseline measurements: BMD at the lumbar spine (LS) and hip (TH), hip geometry, vertebral
deformity assessment, bone turnover markers, physical and cognitive performance, various medical
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and lifestyle factors, and geriatric psychosocial measures confirmed by interviews based on self-
administrated questionnaires.
Outcome surveillance: Annual mail surveys and a follow-up survey at the fifth year comprising
similar items to the baseline study will be used to determine the outcomes. Receipt of benefits from
LCI and mortality will be obtained from the city governments.
Current status: The baseline study was conducted for 2174 eligible men, and 2012 completed the
study and were eligible for follow-up. Prevalence rates of osteoporosis (BMD 2.5 SD or more
below the young adult mean (YAM)) and low BMD (BMD 1 SD or more below YAM) in at least
one of LS and TH were calculated to be 4.4% and 41.8%, respectively. The proportion of men with
low BMD only at TH showed a significant increasing trend with aging (p < 0.0001) while that only
at LS showed a decreasing trend (p = 0.0386). The prevalence rate of osteoporosis was
underestimated when diagnosed using only BMD at LS. Other baseline measurements were
successfully obtained.
Discussion: FORMEN baseline study was performed as designed and the FORMEN cohort study
was successfully launched.
Background
Osteoporotic fracture is a significant and increasing public
health burden, for men as well as women, in aging socie-
ties. The lifetime risk for osteoporotic fracture was esti-
mated to be 40% in women and 13% in men [1]. These
figures, however, may be underestimated by nearly half,
and have been suggested to be as high as 23% in men
when taking future reduction of mortality into account
[2]. The incidence of hip fracture, the most serious oste-
oporotic fracture, is increasing. The number of hip frac-
tures is projected to be 13 million in 2050, with 31% of
these (approximately 4 million), occurring in men [3]. It
has been well established that the incidence rate of hip
fracture is much higher in Caucasians than in Asians [4],
but Asians will account for 45% of hip fractures globally
in 2050 because the population of elderly people in Asia
is increasing dramatically [3]. In Japan, nation-wide sur-
veys for the incidence of hip fracture have been conducted
four times since 1987 [5]. There were 117,900 incident
hip fractures estimated in 2002, double the number from
1987, of which 22% occurred in men [6]. This trend in the
incidence of osteoporotic fractures urges us to establish a
comprehensive strategy to prevent and manage oste-
oporosis in men as a national and international issue with
the highest priority.
In spite of the magnitude of the problem posed by oste-
oporosis in men, there remains a substantial shortage of
information concerning male osteoporosis, especially in
Asia. Only a few prospective cohort studies have been per-
formed for the determinants of osteoporotic fracture in
Hong Kong Chinese men [7] and in Japanese men [8-10].
Some of these have been well performed with a suffi-
ciently high follow-up rate, but the sample size did not
exceed 800, which was not sufficiently large for evaluating
determinants of osteoporotic fractures [8-10]. Further-
more, comprehensive geriatric assessments for the evalua-
tion of risk factors for osteoporotic fracture are lacking.
Without these data, it would be difficult to design rational
clinical and preventive approaches for osteoporosis and
osteoporotic fracture in men. Thus, we have designed and
launched the Fujiwara-kyo Osteoporosis Risk in Men
(FORMEN) Study, a large-scale community-based single-
centre prospective cohort study for elderly Japanese men,
to address the following questions:
1. Does bone mass predict fracture risk in men as has
previously been demonstrated in women?
2. Which lifestyle or medical factors are associated
with fracture risk in men?
3. Do physical performance test results predict fracture
risk in men?
4. Do bone turnover markers enhance the predictive
value of bone density and other clinical risk factors for
fracture risk in men?
5. Does socioeconomic status affect the risk of oste-
oporosis and osteoporotic fracture in men?
6. To what extent do fractures in men increase the risk
of being dependent on care provided from Long-term
Care Insurance (LCI)?
7. To what extent do fractures affect quality of life
(QOL) in men?
8. Do existing vertebral fractures and incident non-ver-
tebral fractures increase risk of death in men?BMC Musculoskeletal Disorders 2009, 10:165 http://www.biomedcentral.com/1471-2474/10/165
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We present in this paper the design of the FORMEN study
and the baseline characteristics of its participants.
Methods/Design
General study description
The FORMEN study is an ancillary study of a larger pro-
spective cohort study, The Cohort Study for Functioning
Capacity and Quality of Life in Elderly Japanese (Primary
Investigator: Norio Kurumatani, M.D., Ph.D., Professor
and Chairman, Department of Community Health and
Epidemiology, Nara Medical University School of Medi-
cine), which is referred to as the "Fujiwara-kyo study" after
the study area where the first capital of Japan, called "Fuji-
wara-kyo," was established in 694 AD. The Fujiwara-kyo
study aims to provide a scientific basis for a comprehen-
sive strategy to prevent frailty, increase the number of
healthy life years, and promote the functioning capacity
and quality of life of the elderly men and women in Japan.
The FORMEN study examines male participants of the
Fujiwara-kyo study for bone health. Most of the non-skel-
etal measurements and interviews were conducted under
the Fujiwara-kyo study, and these data form a comprehen-
sive geriatric and gerontologic basis for the FORMEN
study to evaluate risk factors of osteoporosis and oste-
oporotic fracture of elderly men. Brief explanations of the
Fujiwara-kyo study appear in this paper and details of the
study are described elsewhere. (Kurumatani N, Okamoto
N, Morikawa M, Iwamoto J, Hazaki K, Harano A, Tanaka
K, Minematsu A, Tomioka K, Saeki K, Amano N, Yanagi
M: Protocol and baseline data of a prospective cohort
study (Fujiwara-kyo study) on the change of functioning
capacity and quality of life among physically independent
elderly people: A report from a world's top longevity
country, Japan, submitted)
Study population and recruitment of samples
To achieve the aims of the Fujiwara-kyo study, partici-
pants in the study should be representative of elderly men
and women who are still living independently in a com-
munity and can participate in various preventive activities
conducted by their municipalities. For the inclusion crite-
ria, therefore, participants should be:
(1) aged 65 years or older at baseline,
(2) living in their homes in the cities of Kashihara,
Nara, Yamato-Kooriyama, and Kashiba, which are sur-
rounding areas of the Nara Medical University Hospi-
tal (Figure 1),
(3) able to walk without the assistance of another per-
son,
(4) able to provide self-reported information, and
(5) able to understand and provide written informed
consent.
The FORMEN study included all the male participants of
the Fujiwara-kyo study.
The recruitment of participants was conducted by the
Administrative Centre of the Fujiwara-kyo study with the
cooperation of local residents' associations and elderly
people's clubs organized in every district of the cities stud-
ied. These groups used printed literature that included
information on the aims of the study, study procedures,
risks and benefits posed by study measurements, rights
and responsibilities of participants and researchers, publi-
cation of results, and protection of privacy. The partici-
pants were asked to give written informed consent before
enrolment in the study.
The sample sizes necessary for the Fujiwara-kyo study and
the FORMEN study were set as 4500 and 2000 as
described later, respectively.
Outcome indices
The primary outcome for the FORMEN study is the inci-
dence of osteoporotic fractures, including vertebral frac-
tures and clinical non-vertebral fractures. The additional
outcomes consist of change in bone mineral density
(BMD), change in hip geometry, onset of receiving bene-
fits from LCI, which is an objectively assessed index of
having become physically or cognitively dependent on
other people in daily life, change in QOL, and death.
Study area of the Fujiwara-kyo study Figure 1
Study area of the Fujiwara-kyo study.
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Study measures
Skeletal measures
Bone mass measurement
Bone mineral content (BMC) (g) and bone area (cm2 )
were measured by dual-energy X-ray absorptiometry
(DXA) at the lumbar spine (L2-4) and right hip in a pos-
teroanterior projection (QDR4500A, Hologic Inc., Bed-
ford, MA, USA) as previously described [11]. Participants
with either a history or incident involvement of fractures
or bone disease in the right hip were scanned on the left
side. We excluded densitometric data of the spine for par-
ticipants with vertebral fractures or grade four osteophytes
according to Nathan's classification [12], or those with
hip deformities in the regions of interest (ROI), from the
analysis. All spine and hip measurements throughout the
study were made with one scanner installed in a mobile
test room in a large vehicle. BMD (g/cm2 ) was obtained
by BMC divided by bone area at the lumbar spine (LS)
and total hip (TH). TH was divided into several regions
including the femoral neck (FN) and trochanter (TR). The
short-term precision as measured by the coefficients of
variation (CV) of the BMD measurements in vivo was
1.2%, 1.2%, 1.6% and 1.9% for LS, TH, FN and TR,
respectively. Quality assurance of the measurements was
conducted daily before the study measurements began.
We observed no remarkable drift in BMD values for the
spine phantom throughout the baseline study period.
We defined osteoporosis as BMD values 2.5 SD or more
below the young adult mean (YAM) [13], and low BMD
as 1 SD or more below YAM, in accordance with the WHO
criteria [14].
Hip geometric assessment
The archived DXA image used for calculating BMD at the
hip was subsequently analyzed using Apex software's Hip
Structure Analysis (HSA) program (Hologic Inc., Bedford,
MA, USA). The precise method has been described else-
where [15]. The HSA program automatically set three
ROIs defined as: (1) narrow neck, traversing the narrowest
width of the femoral neck, (2) intertrochanter, along the
bisector of the shaft and femoral neck axes, and (3) shaft,
at 1.5 times the minimum neck width distal from the
intersection of the neck and shaft axes. The HSA program
yielded several hip geometric indices including cross-sec-
tional area, cross-sectional moment of inertia, section
modulus, cortical thickness and subperiosteal diameter
for each of three ROIs.
Vertebral deformity assessment
We imaged the thoracolumbar vertebrae of each partici-
pant by single-energy X-ray absorptiometry (SXA) follow-
ing bone density measurements. Bone morphometric
software (QDR4500A Lateral Image Analyze, Hologic
Inc., Bedford, MA, USA) was used to measure anterior,
central and posterior edge heights of each vertebra using
the SXA images. We diagnosed vertebral deformities
according to the McCloskey-Kanis criteria [16] and used
these as a proxy for vertebral fracture in the baseline study.
We visually confirmed all deformed vertebrae according
to Genant's semiquantitative assessment method [17].
History of symptomatic fractures
History of symptomatic fracture was determined by inter-
viewer-confirmed self-reports from participants. When a
participant reported a symptomatic fracture having
occurred at any time of his life, a trained registered nurse
conducted an in-person interview to determine when the
injury occurred, which bone or part of body was injured,
what activities the participant was engaged in when
injured, and whether a physician diagnosed the injury as
a fracture according to radiographic examinations. We
defined a symptomatic fracture as one which caused a
clinic visit due to pain and was diagnosed as a fracture by
a physician using radiographs.
Bone turnover markers and other laboratory measures
We drew blood from each participant after an overnight
fast and obtained serum for several conventional bio-
chemical tests planned in the Fujiwara-kyo study. We
stored the remaining serum at -80°C until we performed
measurements for the FORMEN study. We measured lev-
els of bone turnover markers including osteocalcin (OC),
undercarboxylated OC (ucOC), and tartrate-resistant acid
phosphatase isoenzyme 5b (TRACP-5b). In addition, we
will measure Type I collagen cross-linked C-terminal tel-
opeptide (CTX) and type I procollagen N-terminal
propeptide (P1NP). As non-skeletal markers, we meas-
ured serum levels of high-sensitivity CRP and homo-
cysteine.
We measured OC [ng/ml] using a two-site immunoradio-
metric assay (BGP IRMA kit Mitsubishi, Mitsubishi
Kagaku Iatron Inc., Tokyo, Japan) with a sensitivity of 1
ng/ml [18]. The precision of this measurement was 4.9%,
3.7% and 6.1% for intraassay CV, interassay CV and over-
all CV, respectively.
We used an electrochemiluminescence immunoassay to
measure ucOC [ng/ml] (Picolumi ucOC, Sanko Junyaku
Co. Ltd., Tokyo, Japan) with a sensitivity of 0.39 ng/ml
[19]. The precision of this measurement was 4.1%, 3.5%
and 5.4% for intraassay CV, interassay CV and overall CV,
respectively.
TRACP-5b was measured by a fragment-absorbed immu-
nocapture enzyme assay (Osteolinks-TRAP-5b, Nitto
Boseki, Kooriyama, Japan) with a sensitivity of 19.2 mU/
dl [20]. The intraassay CV, interassay CV and overall CV of
this measurement in our laboratory were 4.9%, 7.3% and
8.8%, respectively.BMC Musculoskeletal Disorders 2009, 10:165 http://www.biomedcentral.com/1471-2474/10/165
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Serum levels of CTX and P1NP will be measured using an
enzyme-linked immunoassay (Serum CrossLaps ELISA,
Immunodiagnostic Systems Ltd., Boldon, UK)[21] and a
two-site electrochemiluminescence immunoassay (Roche
Elecsys 2010, Roche Diagnostics, Lewes, UK)[22], respec-
tively.
Non-skeletal measures
Non-skeletal measures were obtained in the Fujiwara-kyo
study. We state briefly here some measures relevant to the
FORMEN study.
Clinical measures
We measured participant height (cm), weight (kg) and
waist circumference (cm), and calculated body mass index
(BMI)(kg/m2 ).
Physical and cognitive performance measures
A series of physical performance tests for elderly people
were conducted including grip strength, muscle strength
of knee extensors and flexors, brisk gait speed, the timed
up-and-go test, and the timed one-leg balance with eyes
open. To quantify cognitive function, participants com-
pleted the Modified Mini-Mental State Examination [23].
Medical history, and gerontological lifestyle and socioeconomic 
factors
Participants completed a questionnaire including 250
items covering medical history including thyroid diseases,
parathyroid diseases, rheumatoid arthritis, connective tis-
sue diseases, malignant diseases, hypertension, diabetes
mellitus, coronary heart diseases, hyperlipidemia,
asthma, kidney diseases and prostate diseases, history of
medications due to these diseases, several scales of geriat-
ric and gerontological factors, smoking and drinking his-
tory, diet history including intake of dairy products and a
fermented soy bean product called 'natto' in Japanese,
physical activity indices necessary for quantification using
the International Physical Activity Questionnaire (IPAQ)
[24], fall and fracture history, family history of fractures,
symptoms in back and joints, level of education, social
and economic status, and marital status. Participants were
asked to bring current prescriptions of medications to the
baseline visit where interviewers recorded the name and
dose of the medications. Participants were also asked to
complete a seven-day diary of their diets to estimate die-
tary nutrient intakes.
Quality of life assessment
Health-related quality of life was assessed with the 36-
item short form of the Medical Outcomes Study Ques-
tionnaire (SF-36) [25].
Outcome surveillance
To obtain outcome indices, annual mail surveys and a fol-
low-up survey in the fifth year comprising similar study
items to the baseline study will be conducted as part of the
Fujiwara-kyo study.
Incident vertebral fractures
An incident vertebral fracture is diagnosed morphometri-
cally based on SXA images of the spine when the anterior,
central or posterior height of a vertebra is reduced by 20%
or more on follow-up compared to baseline, and when
the vertebra also satisfied the McCloskey-Kanis criteria
[16]. Vertebrae with heights reduced by 20% or more
which do not satisfy the McCloskey-Kanis criteria are con-
sidered to be incident fractures if they satisfy the defini-
tion of grade 2 or 3 fracture by the Genant method [17].
Change in bone density and hip geometry
Bone densitometry will be conducted in the follow-up
survey at the same skeletal sites with the same densitome-
ter as used in the baseline study. Changes in BMD at LS,
TH, FN and TR, and in hip geometry indices will be deter-
mined.
Non-vertebral and symptomatic vertebral fractures
When a participant reports on the annual questionnaire
the occurrence of fracture in the previous year, a trained
nurse will conduct a telephone interview and obtain
details of the injury to determine whether the injury is a
fracture or not. Reviews of participant medical records will
be further conducted with the written permission of the
participant.
Onset of receiving benefits from LCI and death of participants
We will obtain information regarding whether a partici-
pant starts receiving benefits from LCI from response to
the annual questionnaire. In the case that a participant
dies in the previous year, the family is to inform the
Administrative Centre of the Fujiwara-kyo study of the
participant's death. When a participant does not respond
to the annual questionnaire, the Administrative Centre
will contact the city office and obtain the information on
the participant's receipt of benefits and survival. Partici-
pants have given the researchers their consent to this
inquiry.
Statistical analysis
Primary analyses
The primary analyses consist of assessments of baseline
risk factors for the primary and additional outcomes of
the study. The risk factors will be thoroughly investigated
from among the skeletal and non-skeletal measures
obtained at baseline. To evaluate risk factors for vertebral
fractures and clinical non-vertebral fractures, we will con-
duct logistic regression analysis and Cox proportional
hazards regression analysis, respectively. Factors associ-
ated with changes in BMD and hip geometry indices will
be evaluated by multiple regression analysis. The propor-
tional hazards regression will also be applied to evaluateBMC Musculoskeletal Disorders 2009, 10:165 http://www.biomedcentral.com/1471-2474/10/165
Page 6 of 11
(page number not for citation purposes)
risk factors for receiving benefits from LCI, and mortality.
Determinants for changes in QOL will be evaluated by
multiple regression analysis. Additional effects of the inci-
dence of osteoporotic fractures during follow-up on
receiving LCI benefits, changes in QOL and survival will
be evaluated after adjusting for their potential risk factors
at baseline.
Additional analyses
Additional analyses, mostly cross-sectional, are being con-
ducted for provisional assessments of known and poten-
tial risk factors for the outcome indices. These include the
effects of socioeconomic status, medical histories, physi-
cal and cognitive performance, and lifestyle factors
including smoking, drinking, milk consumption and
"natto" intake on BMD, low BMD, and vertebral fractures.
Sample size calculations
The sample size necessary for the FORMEN study was set
as 2000. This was obtained in order that the logistic
regression analysis yields a significant estimate with a
two-tailed level of significance at 5% and a statistical
power of 80% for a risk factor of fracture which exists in
20% of the population and increases the fracture risk by
75% compared with people without the risk factor who
run the absolute fracture risk of 1% per year. The statistical
power afforded by the sample size of 2000 under several
other assumptions is shown in Table 1.
Study time line
The complete schedule of the Fujiwara-kyo study is illus-
trated in Figure 2. The study enrolled participants and
completed the baseline survey from June 2007 to October
2008. A follow-up survey covering most of the items
examined in the baseline survey is scheduled in 2012 after
an average follow-up period of 4.5 years. During the
interim, the participants are asked to respond to annual
mailed questionnaires for the surveillance of the outcome
indices of the study. The third annual questionnaire cov-
ers more extensive items to update important information
obtained at baseline.
Study administration
The Administrative Centre of the Fujiwara-kyo study is
organized in the Department of Community Health and
Epidemiology, Nara Medical University School of Medi-
cine. The Core Member Committee, established as a steer-
ing committee of the study, is chaired by the Principal
Investigator and composed of core investigators from all
the study areas. This committee takes responsibility for
designing the primary scope of the study, developing pro-
tocols, organizing subcommittees for ancillary studies,
setting specific research directions and goals, sharing pub-
lication opportunities, and smoothing inter-institutional
collaborations. Core investigators are responsible for
designing protocols for their specific area of study, con-
ducting the measurements at the surveys, and collecting
and collating the data for their areas of responsibility.
Table 1: Statistical power expected for logistic analysis under a sample size of 2000 with various assumptions.
Risk factor studied Annual incidence rate of fracture (%) in population without a risk factor studied
Prevalence rate (%) RR 0.8 1 1.5 2 PARP (%)
20 1.25 14 18 24 41 4.8
1.5 41 50 68 81 9.1
1.75 72 81 94 99 13.0
2 91 96 100 100 16.7
30 1.25 17 21 30 38 7.0
1.5 43 59 78 89 13.0
1.75 80 88 98 100 18.4
2 95 98 100 100 23.1
40 1.25 19 23 32 42 9.1
1.5 53 63 81 92 16.7
1.75 83 91 98 100 23.1
2 96 99 100 100 28.6
Statistical power was estimated for a logistic regression analysis to yield a significant estimate for a risk factor with a two-tailed level of significance 
at 5% under a sample size of 2000 with various combinations of assumptions.
RR: Relative risk of fracture posed by a risk factor studied.
PARP: Population attributable risk proportion.
Boldface: Power > 80%
81: Assumptions used when the present sample size of 2000 was determined.BMC Musculoskeletal Disorders 2009, 10:165 http://www.biomedcentral.com/1471-2474/10/165
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The FORMEN Administrative Center is organized in the
Department of Public Health, Kinki University School of
Medicine, to conduct the FORMEN study smoothly in
close cooperation with the Fujiwara-kyo study.
The study protocol of the Fujiwara-kyo study was
approved by the Medical Ethics Committee of the Nara
Medical University, and that of the FORMEN study was
approved by the Ethics Committee of the Kinki University
School of Medicine.
Current status
Participant recruitment
During the baseline study period, 2174 men and 2253
women participated in the Fujiwara-kyo study. Among the
male participants, 2012 men completed the measure-
ments conducted in the FORMEN study and were eligible
for further analyses and the cohort study. The average age
of the participants was 73.3 ± 5.3 (mean ± SD) years with
a range of 65 to 94 years. They were 162.8 ± 5.7 cm tall,
weighed 60.9 ± 8.6 kg, and had a mean BMI of 22.9 ± 2.8.
Table 2 shows comparisons of age distribution and body
size parameters between FORMEN study participants and
the male population of Nara Prefecture[26,27] or Japan
[26,28]. The FORMEN participants comprised a higher
proportion of men aged 70-79 and were slightly taller
than the general population of Japan, but were very simi-
lar in body size to men in Nara Prefecture.
Characteristics of participants
Medical history and lifestyle factors
Medical history and lifestyle factors of the study partici-
pants are listed in Table 3. The prevalence rate of cerebrov-
ascular diseases and malignant diseases including prostate
cancer increased with aging. Lifestyle factors listed in this
table were all significantly related to age. With the increase
in age, participants drank more milk, smoked less, drank
less alcohol and expended less energy. We also obtained
information regarding other lifestyle factors, including
dietary intake and exercise history, which will be pre-
sented in future publications.
Skeletal measures
Skeletal measures of the study participants are shown in
Table 4, stratified by age. BMD and BMC at LS were not
significantly correlated with age, while those at TH, FN
and TR were. Bone area did not clearly show an associa-
tion with age. When adjusted for height and weight, BMD
at TH still decreased with age (partial regression coeffi-
cient of -0.016 [SE 0.005] g/cm2 /10 years [p < 0.0001]),
but BMD at LS increased significantly (0.042 [0.008] g/
cm2 /10 years [p < 0.0001]). The levels of biochemical
markers, such as OC, ucOC, and TRACP-5b increased with
aging as well.
Time line of the Fujiwara-kyo study Figure 2
Time line of the Fujiwara-kyo study.
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Table 2: Age and body size between FORMEN participants and male population of Nara Prefecture or Japan
Index Population 65-69 years 70-74 years 75-79 years 80 years and older
Age FORMEN study 627 (31.2%) 705 (35.0%) 450 (22.4%) 230 (11.4%)
distribution Nara Prefecturea 34.7% 28.0% 20.3% 16.9%
Japana 33.2% 28.1% 20.6% 18.1%
Height (cm) FORMEN study 164.8 ± 5.9 163.2 ± 5.9 162.7 ± 6 160.5 ± 6.4
Nara Prefectureb 165.5 ± 6.2 164.1 ± 6.3 162.3 ± 6.3 160.5 ± 6.8
Japanc 163.7 ± 6.5 162.2 ± 6.9 161.0 ± 6.3 158.9 ± 8.0
Weight (kg) FORMEN study 63.3 ± 9.1 62.0 ± 8.6 60.0 ± 8.6 56.8 ± 8.8
Nara Prefectureb 64.1 ± 9.2 62.8 ± 9.5 60.1 ± 9.2 56.6 ± 9.9
Japanc 64.4 ± 9.7 62.0 ± 8.7 59.7 ± 8.4 56.0 ± 9.6
BMI (kg/m2) FORMEN study 23.7 ± 3.2 23.7 ± 3.1 23.1 ± 3.3 22.4 ± 3.3
Nara Prefectureb 23.8 ± 3.3 23.8 ± 3.4 23.2 ± 3.5 22.4 ± 3.6
Japanc 24.4 ± 3.6 24.0 ± 3.4 23.4 ± 3.1 22.6 ± 3.5
a Population Statistics based on the Basic Resident Registry [26]
b Annual Report of Basic Health Examinations 2007 [27]
c National Health and Nutrition Survey 2006 [28]BMC Musculoskeletal Disorders 2009, 10:165 http://www.biomedcentral.com/1471-2474/10/165
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The prevalence rates of osteoporosis in the FORMEN par-
ticipants were 3.5% at LS, 1.9% at TH, and 4.4% in at least
one of LS and TH. The prevalence rates of low BMD were
26.4%, 33.9% and 41.8%, respectively. Figure 3 illustrates
proportions of low BMD categories in the participants in
10-year age groupings. The proportion of men whose
BMD was judged to be low only at TH showed a signifi-
cant increase with increase in age (p < 0.0001), while low
BMD only at LS showed a decreasing trend with increasing
age (p = 0.0386). Diagnosis of low BMD was not well cor-
related with BMD at LS and TH, with a kappa coefficient
of 0.45. Other skeletal measures, including diagnosis of
vertebral deformities and hip geometry indices, are being
analyzed and will be presented in future papers.
Non-skeletal measures
Physical performance tests and cognitive performance
tests were carried out successfully in most participants.
The database is under construction and the results will be
presented in future reports. We were also successful in
obtaining QOL indices.
Discussion
The FORMEN study is a large-scale community-based sin-
gle-centre study for elderly Japanese men with compre-
hensive geriatric and gerontologic assessments for
potential risk factors of osteoporosis and osteoporotic
fractures. We have successfully conducted the baseline
study as designed, and will carry out longitudinal observa-
tions for at least five years as a prospective cohort study.
The FORMEN study has some strengths compared with
previous studies. First, the sample size of the FORMEN
study is the largest in Japan, allowing for a high enough
statistical power to evaluate risk factors of vertebral or
osteoporotic fractures. Second, it has a comprehensive
coverage of skeletal measures relevant to osteoporosis
assessment, including vertebral deformity assessment and
HSA in addition to conventional BMD measurement.
Third, biochemical markers of bone turnover in sera were
measured for all participants, and the remaining sera are
stored at -80°C for further measurements of newer mark-
ers. Fourth, it has comprehensive coverage of potential
Table 3: Baseline characteristics of participants stratified by age in the FORMEN baseline study, 2007-2008
All age groups 65-69 years 70-74 years 75-79 years 80 years and older P value a
Past history and present involvement of diseases (%)
Thyroid diseases 1.4 1.3 1.3 0.7 3.9 0.0915
Rheumatoid arthritis and connective tissue 
diseases
1.0 1.0 0.9 0.7 2.2 0.3419
Diabetes mellitus 10.1 9.4 10.7 10.9 8.7 0.9221
Asthma 1.2 1.6 0.7 1.3 1.3 0.7719
Hypertension 33.3 30.2 35.0 35.6 31.7 0.2787
Cerebrovascular diseases 3.7 2.6 2.8 6.4 3.9 0.0137
Coronary heart disease 4.7 4.3 4.6 4.9 5.7 0.4090
Malignant diseases 8.2 6.2 0.4 9.1 11.3 0.0115
Prostate cancer 2.4 1.6 2.1 3.8 3.0 0.0391
Steroid use 0.9 1.1 0.6 1.1 1.3 0.7588
Statin use 4.9 4.8 5.4 3.1 7.0 0.8217
Fragility fractures since age 50 4.4 1.2 4.4 4.9 4.4 0.7019
Lifestyle factors
Milk consumption (%)
2 glasses/day or more 8.1 6.2 8.4 9.1 10.0 0.0088
1 glass/day 43.2 40.4 43.9 40.4 53.9
Several glasses/week 15.2 16.6 15.5 16.2 8.7
1 glass/week or less 33.5 36.7 32.3 34.2 27.4
Smoking status (%)
Current smokers 17.0 21.9 17.3 14.3 7.9 <0.0001
Ex-smokers 61.4 56.6 59.8 65.1 71.9
Non-smokers 21.7 21.5 23.0 20.8 20.2
Number of pack-years in ever-smokers 41.1 ± 28.3 40.8 ± 28.5 43.2 ± 27.8 39.2 ± 27.8 39.9 ± 29.5 0.3908
Alcohol drinking habit (%)
Less than once/week 38.0 33.3 37.8 40.9 45.8 0.0218
1-2 times/week 5.3 5.3 4.7 5.8 6.2
3-5 times/week 8.9 10.4 8.9 7.4 7.5
6 times/week or more 47.9 51.0 48.6 45.9 40.5
Values represent mean ± SD, median with interquartile limits in parentheses, or proportion.
a A trend of each variable with aging was tested by a linear regression-based trend test or Cochran-Armitage trend test. Chi-squared test was 
applied when a variable had more than two categories.BMC Musculoskeletal Disorders 2009, 10:165 http://www.biomedcentral.com/1471-2474/10/165
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risk factors of osteoporosis and osteoporotic fractures
based on geriatric and gerontologic assessments. Fifth, we
have established highly reliable surveillance of outcome
indices using official municipality databases, including
onset of becoming dependent on others in daily life and
mortality. Finally, a single-centre study design has an
advantage over a multi-centre design with respect to qual-
ity control of study performance given that no inter-centre
calibrations of study measurements are necessary.
The FORMEN study also has potential limitations. First,
participants were not randomly selected, which makes
generalizing the results obtained difficult. However, the
Fujiwara-kyo study aims to apply the results to people liv-
ing independently in the communities studied, and our
results can be utilized for this purpose. Second, the sam-
ple size of the FORMEN study may still be small for assess-
ing risk factors of hip fracture. Third, BMD measurements
did not include whole body BMD or volumetric BMD
obtained by quantitative computed tomography. Fourth,
vertebral deformity detected with SXA images might
Table 4: Skeletal measures of participants stratified by age in the FORMEN baseline study, 2007-2008
Index All age groups 65-69 years 70-74 years 75-79 years 80 years and older P for trend
BMD (g/cm2 )
LS 1.026 ± 0.191 1.022 ± 0.177 1.023 ± 0.185 1.030 ± 0.199 1.042 ± 0.226 0.1877
TH 0.878 ± 0.126 0.901 ± 0.124 0.880 ± 0.121 0.864 ± 0.129 0.841 ± 0.130 <0.0001
FN 0.740 ± 0.116 0.763 ± 0.117 0.741 ± 0.111 0.720 ± 0.114 0.715 ± 0.118 <0.0001
TR 0.684 ± 0.112 0.702 ± 0.109 0.685 ± 0.107 0.674 ± 0.117 0.651 ± 0.119 <0.0001
BMC (g)
LS 54.3 ± 13.3 54.2 ± 12.1 54.2 ± 13.4 54.5 ± 14.1 54.4 ± 14.4 0.7020
TH 36.5 ± 6.1 37.4 ± 6.3 36.5 ± 5.8 36.0 ± 5.9 35.2 ± 6.3 <0.0001
FN 3.9 ± 0.6 4.0 ± 0.6 3.9 ± 0.6 3.8 ± 0.6 3.8 ± 0.7 <0.0001
TR 8.9 ± 2.5 9.2 ± 3.5 8.9 ± 1.8 8.8 ± 1.8 8.5 ± 2.0 <0.0001
Area (cm2 )
LS 51.9 ± 5 52.2 ± 4.6 51.8 ± 5.1 52.0 ± 5.1 50.9 ± 5.2 0.0039
TH 41.6 ± 3.5 41.5 ± 3.6 41.5 ± 3.4 41.7 ± 3.3 41.8 ± 3.6 0.1959
FN 5.3 ± 0.4 5.2 ± 0.3 5.3 ± 0.4 5.3 ± 0.3 5.3 ± 0.3 0.0801
TR 13.0 ± 2.0 13.1 ± 2.7 13.0 ± 1.5 13.0 ± 1.5 13.1 ± 1.6 0.6968
Biochemical marker of bone turnover
OC (ng/ml) 4.8 (3.2, 6.5) 4.5 (2.6, 6.1) 4.8 (3.2, 6.5) 5.0 (3.5, 6.8) 5.4 (4.0, 6.9) <0.0001
ucOC (ng/ml) 2.9 (1.5, 5.4) 2.7 (1.5, 4.9) 2.9 (1.6, 5.4) 3.0 (1.6, 5.7) 3.4 (1.8, 6.4) <0.0001
TRACP-5b (mU/dl) 212.3 (121.7, 370.4) 200.2 (115.0, 348.7) 211.0 (120.2, 370.5) 212.3 (122.0, 369.3) 254.0 (152.5, 423.3) <0.0001
BMD: Bone mineral density
BMC: Bone mineral content
LS: Lumbar spine TH: Total hip FN: Femoral neck TR: Trochanter
OC: Osteocalcin
ucOC: Undercarboxylated osteocalcin
TRACP-5b: Tartrate resistant acid phosphatase isoenzyme 5b
Values of bone densitometric measures represent mean ± SD.
OC values represent median with interquartile limits in parentheses.
ucOC and TRACP-5b values represent geometric mean with values for M-SD and M+SD in parentheses.
Bone densitometric data at the spine and at the hip were obtained from 1916 and 2008 participants, respectively, without severe deformities in the 
region of interest.
Number of participants with available measurements for OC, ucOC and TRACP-5b were 1971, 1970 and 2003, respectively.
Proportions of BMD categories in age-stratified participants  of the FORMEN baseline study, 2007-2008 Figure 3
Proportions of BMD categories in age-stratified par-
ticipants of the FORMEN baseline study, 2007-2008. 
BMD: Bone mineral density. Normal: BMD greater than 1 SD 
below the young adult mean (YAM). Low BMD: BMD 1 SD 
or more below YAM. LS: Lumbar spine. TH: Total hip. Data 
of 1912 subjects with BMD values available for both skeletal 
sites were used in the analysis.
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underestimate the prevalence of vertebral fractures com-
pared to diagnosis with conventional radiographs. Fifth,
urinary levels of bone turnover markers were not meas-
ured, although more novel serum markers were included.
Finally, the deaths of participants will be confirmed, but a
survey for the cause of death is not included in the initial
study protocol.
Such potential limitations of the FORMEN study may
have some effects on the study results, but are not
expected to invalidate the results. In turn, they may sug-
gest some directions for future research. The study items
of the FORMEN study cover most items of preceding stud-
ies, such as the Mr OS study [29]. It may be possible to
combine the results with those from other studies to
increase the statistical power. Extending the follow-up
period of the FORMEN study is worthwhile, and can
increase the power as well. New random sample studies
may be desirable to generalize study results to the whole
population.
Conclusions
The FORMEN study, a large-scale community-based sin-
gle-centre prospective cohort study for elderly Japanese
men with comprehensive coverage of potential risk factors
of osteoporosis and osteoporotic fractures, designed as an
ancillary study of the Fujiwara-kyo study, was successfully
launched for longitudinal observations for at least five
years. The study is expected to clarify a range of risk factors
for osteoporotic fractures, to form predictive models of
fracture risk, and to assess consequences of fractures in
Japanese elderly men. These results should help health
care professionals improve their preventive activities and
management of osteoporosis in men.
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